Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cost-effectiveness of clinical remission by treat to target strategy in established rheumatoid arthritis: results of the CREATE registry.
Cárdenas M, de la Fuente S, Castro-Villegas MC, Romero-Gómez M, Ruiz-Vílchez D, Calvo-Gutiérrez J, Escudero-Contreras A, Del Prado JR, Collantes-Estévez E, Font P. Cárdenas M, et al. Among authors: font p. Rheumatol Int. 2016 Dec;36(12):1627-1632. doi: 10.1007/s00296-016-3583-3. Epub 2016 Oct 24. Rheumatol Int. 2016. PMID: 27778067
Real-world cost-effectiveness of infliximab, etanercept and adalimumab in rheumatoid arthritis patients: results of the CREATE registry.
Cárdenas M, de la Fuente S, Font P, Castro-Villegas M, Romero-Gómez M, Ruiz-Vílchez D, Calvo-Gutiérez J, Escudero-Contreras A, Casado M, Del Prado J, Collantes-Estévez E. Cárdenas M, et al. Among authors: font p. Rheumatol Int. 2016 Feb;36(2):231-41. doi: 10.1007/s00296-015-3374-2. Rheumatol Int. 2016. PMID: 26494567
Optimization of biological therapy in rheumatoid arthritis patients: outcomes from the CREATE registry after 2 years of follow-up.
Cárdenas MJ, de la Fuente S, Castro-Villegas MC, Romero-Gómez M, Ruiz-Vílchez D, Calvo-Gutiérrez J, Escudero-Contreras A, Del Prado JR, Collantes-Estévez E, Font P. Cárdenas MJ, et al. Among authors: font p. Rheumatol Int. 2017 Oct;37(10):1701-1708. doi: 10.1007/s00296-017-3757-7. Epub 2017 Jun 9. Rheumatol Int. 2017. PMID: 28597307
Integrative Clinical, Molecular, and Computational Analysis Identify Novel Biomarkers and Differential Profiles of Anti-TNF Response in Rheumatoid Arthritis.
Luque-Tévar M, Perez-Sanchez C, Patiño-Trives AM, Barbarroja N, Arias de la Rosa I, Abalos-Aguilera MC, Marin-Sanz JA, Ruiz-Vilchez D, Ortega-Castro R, Font P, Lopez-Medina C, Romero-Gomez M, Rodriguez-Escalera C, Perez-Venegas J, Ruiz-Montesinos MD, Dominguez C, Romero-Barco C, Fernandez-Nebro A, Mena-Vazquez N, Marenco JL, Uceda-Montañez J, Toledo-Coello MD, Aguirre MA, Escudero-Contreras A, Collantes-Estevez E, Lopez-Pedrera C. Luque-Tévar M, et al. Among authors: font p. Front Immunol. 2021 Mar 23;12:631662. doi: 10.3389/fimmu.2021.631662. eCollection 2021. Front Immunol. 2021. PMID: 33833756 Free PMC article.
Molecular Changes in the Adipose Tissue Induced by Rheumatoid Arthritis: Effects of Disease-Modifying Anti-Rheumatic Drugs.
Arias de la Rosa I, Escudero-Contreras A, Ruiz-Ponce M, Román-Rodríguez C, Pérez-Sánchez C, Ábalos-Aguilera MDC, Ortega-Castro R, Alcaide J, Murri M, Font P, Calvo-Gutiérrez J, Luque-Tevar M, Patiño-Trives AM, Guzmán-Ruiz R, Malagón MDM, Tinahones FJ, Collantes-Estévez E, López-Pedrera C, Barbarroja N. Arias de la Rosa I, et al. Among authors: font p. Front Immunol. 2021 Oct 13;12:744022. doi: 10.3389/fimmu.2021.744022. eCollection 2021. Front Immunol. 2021. PMID: 34721412 Free PMC article.
Complement component 3 as biomarker of disease activity and cardiometabolic risk factor in rheumatoid arthritis and spondyloarthritis.
Arias de la Rosa I, Font P, Escudero-Contreras A, López-Montilla MD, Pérez-Sánchez C, Ábalos-Aguilera MC, Ladehesa-Pineda L, Ibáñez-Costa A, Torres-Granados C, Jimenez-Gomez Y, Patiño-Trives A, Luque-Tévar M, Castro-Villegas MC, Calvo-Gutiérrez J, Ortega-Castro R, López-Pedrera C, Collantes-Estévez E, Barbarroja N. Arias de la Rosa I, et al. Among authors: font p. Ther Adv Chronic Dis. 2020 Oct 21;11:2040622320965067. doi: 10.1177/2040622320965067. eCollection 2020. Ther Adv Chronic Dis. 2020. PMID: 33796240 Free PMC article.
Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation.
Ruiz-Limón P, Ortega R, Arias de la Rosa I, Abalos-Aguilera MDC, Perez-Sanchez C, Jimenez-Gomez Y, Peralbo-Santaella E, Font P, Ruiz-Vilches D, Ferrin G, Collantes-Estevez E, Escudero-Contreras A, López-Pedrera C, Barbarroja N. Ruiz-Limón P, et al. Among authors: font p. Transl Res. 2017 May;183:87-103. doi: 10.1016/j.trsl.2016.12.003. Epub 2016 Dec 9. Transl Res. 2017. PMID: 28027930
Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy.
Ibáñez-Costa A, Perez-Sanchez C, Patiño-Trives AM, Luque-Tevar M, Font P, Arias de la Rosa I, Roman-Rodriguez C, Abalos-Aguilera MC, Conde C, Gonzalez A, Pedraza-Arevalo S, Del Rio-Moreno M, Blazquez-Encinas R, Segui P, Calvo J, Ortega Castro R, Escudero-Contreras A, Barbarroja N, Aguirre MA, Castaño JP, Luque RM, Collantes-Estevez E, Lopez-Pedrera C. Ibáñez-Costa A, et al. Among authors: font p. Ann Rheum Dis. 2022 Jan;81(1):56-67. doi: 10.1136/annrheumdis-2021-220308. Epub 2021 Oct 8. Ann Rheum Dis. 2022. PMID: 34625402 Free PMC article.
Comparison of the clinical expression of patients with ankylosing spondylitis from Europe and Latin America.
Benegas M, Muñoz-Gomariz E, Font P, Burgos-Vargas R, Chaves J, Palleiro D, Maldonado Cocco J, Gutiérrez M, Sáenz R, Steckmen I, Rillo O, Mulero J, Sampaio-Barros P, Barcelos A, Vander Cruyssen B, Vazquez-Mellado J, Collantes Estevez E; RESPONDIA group; ASPECT study group; REGISPONSER study group. Benegas M, et al. Among authors: font p. J Rheumatol. 2012 Dec;39(12):2315-20. doi: 10.3899/jrheum.110687. Epub 2012 Nov 12. J Rheumatol. 2012. PMID: 23149388
95 results